LiverScreen | Changing the paradigm of diagnosis for Chronic Liver DiseasesLiverScreen - LiverScreen

LiverScreen | Changing the paradigm of diagnosis for Chronic Liver DiseasesLiverScreen - LiverScreen

LiverScreen

Screening for liver fibrosis population-based study across European countries

Study Design: Observational study

Intervention: N/A

Start date: 1st January 2020

Length of Study: 5,5 years

# of Participants: 19

# of Countries: 10

Highlights

Very important news from LiverScreen
There is an urgent need to change the current paradigm for diagnosing chronic liver diseases by detecting asymptomatic, reversible liver fibrosis early, before cirrhosis and complications develop. Read the new article out now on Nature Medicine: Screening for fibrosis to diagnose liver diseases early: the LIVERSCREEN project
Increased risk of extra-hepatic neoplasms in NAFLD
Nonalcoholic Fatty Liver Disease in women with polycystic ovary syndrome
14^th International Meeting on Therapy in Liver Diseases
NAFLD and risk of dementia
Combined strategies for the treatment of NAFLD
Adherence to lifestyle changes in patients with Non-Alcoholic Fatty Liver Disease (NAFLD)

Latest news

Coordinator’s contacts:
Prof Pere Ginès,MD, PhD
Liver Unit – Hospital Clínic
University of Barcelona – IDIBAPS
pgines@clinic.cat